`Patent 7,879,828
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`INITIATIVE FOR RESPONSIBILITY IN DRUG PRICING LLC,
`Petitioner
`
`v.
`
`WYETH LLC
`Patent Owner
`
`
`Case IPR2014-01259
`
`Patent 7,879,828
`
`
`
`
`
`
`
`
`
`SUBMISSION OF MANDATORY NOTICE INFORMATION
`PURSUANT TO 37 C.F.R. § 42.8(a)(2)
`
`Pursuant to 37 C.F.R. § 48.2(a)(2), Patent Owner Wyeth LLC submits the
`
`
`
`following mandatory notice information.
`
`
`
`
`
`Case IPR2014-01259
`Patent 7,879,828
`
`
`REAL PARTY-IN-INTEREST
`
`Wyeth LLC, a Delaware limited liability company having a place of
`
`business at 235 East 42nd Street, New York, New York 10017, is the owner of the
`
`entire interest in U.S. Patent No. 7,879,828 (“the ’828 patent”). PF PRISM, C.V.,
`
`a limited partnership (commanditaire vennootschap) organized and existing under
`
`the laws of the Netherlands and having offices at Blaak 40 basement, 3011 TA,
`
`Rotterdam, Netherlands, took an exclusive license in the ’828 patent. Thereafter,
`
`PF PRISM C.V. contributed its rights under the exclusive license to Pfizer
`
`Pharmaceuticals LLC, a Delaware limited liability company having a place of
`
`business at Bo. Carmelitas, Road 689, Km 1.9, Vega Baja, Puerto Rico 00693.
`
`Wyeth LLC, PF PRISM C.V., and Pfizer Pharmaceuticals LLC are wholly-owned,
`
`directly or indirectly, by Pfizer Inc., a publicly-traded company.
`
`
`
`2
`
`
`
`Case IPR2014-01259
`Patent 7,879,828
`
`
`RELATED MATTERS
`
`The following judicial and administrative matters could affect, or be affected
`
`by, a decision in this proceeding:
`
`• The ’828 patent has been asserted in the following litigation, which is
`
`currently pending: Pfizer Inc., et al. v. Fresenius Kabi USA, LLC, No.
`
`1:13-cv-01893-SLR (D. Del.); Pfizer Inc., et al. v. CFT
`
`Pharmaceuticals, LLC, No. 1:14-cv-00781-SLR (D. Del.); Pfizer Inc.,
`
`et al. v. Aurobindo Pharma Ltd., et al., No. 1:14-cv-00 872-SLR (D.
`
`Del.)
`
`• The ʼ828 patent is the subject of the following IPR proceeding,
`
`instituted, and currently pending: Apotex, Inc. v Wyeth, LLC, Case
`
`IPR2014-00115.
`
`• There is also litigation pending in the United States District Court for
`
`the District of Delaware between Apotex, Inc. and the Patent Owner
`
`arising from Apotex’s submission of an Abbreviated New Drug
`
`Application to market a generic version of Pfizer’s drug Tygacil ®.
`
`Pfizer Inc., et al. v. Apotex Inc., et al., 1:13-cv-01613-SLR (D. Del.).
`
`The ’828 patent is not asserted in that case because Apotex did not
`
`assert pursuant to 21 U.S.C. § 355(b)(2)(A)(iv) that the ’828 patent
`3
`
`
`
`
`
`Case IPR2014-01259
`Patent 7,879,828
`
`
`was invalid or would not be infringed by the manufacture, use, or sale
`
`of the drug covered by Apotex’s Abbreviated New Drug Application.
`
`• Patent Application Number 13/011,164, which was filed on January
`
`21, 2011, is pending and claims the benefit of Application Number
`
`11/374,330, which is an application in the chain leading to issuance of
`
`the ’828 patent.
`
`
`
`4
`
`
`
`Case IPR2014-01259
`Patent 7,879,828
`
`
`LEAD AND BACK-UP COUNSEL
`
`
`
`Patent Owner Wyeth LLC designates the following lead and back-up
`
`counsel:
`
`Back-Up Counsel
`David I. Berl
`Reg. No. 72,751
`Williams & Connolly LLP
`725 Twelfth Street, N.W.
`Washington, DC 20005
`202-434-5491 (Telephone)
`202-434-5029 (Facsimile)
`dberl@wc.com
`
`Galina I. Fomenkova
`Reg. No. 72,583
`Williams & Connolly LLP
`725 Twelfth Street, N.W.
`Washington, DC 20005
`202-434-5760 (Telephone)
`202-434-5029 (Facsimile)
`gfomenkova@wc.com
`
`
`Lead Counsel
`
`
`
`Stanley E. Fisher
`
`Reg. No. 55,820
`
`Williams & Connolly LLP
`725 Twelfth Street, N.W.
`Washington, DC 20005
`
`202-434-5289 (Telephone)
`202-434-5029 (Facsimile)
`sfisher@wc.com
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`5
`
`
`
`Case IPR2014-01259
`Patent 7,879,828
`
`
`SERVICE INFORMATION
`
`sfisher@wc.com
`dberl@wc.com
`tselby@wc.com
`aharber@wc.com
`gfomenkova@wc.com
`mkidd@wc.com
`jeff.rennecker@pfizer.com
`robyn.popeck@pfizer.com
`
`Stanley E. Fisher
`Williams & Connolly LLP
`725 Twelfth Street, N.W.
`Washington, DC 20005
`
`Same as above
`
`202-434-5289
`
`202-434-5029
`
`(i)
`
`Electronic mail addresses:
`
`
`
`(ii) Postal mailing address:
`
`(iii) Hand-delivery address:
`
`(iv) Telephone Number:
`
`
`
`Facsimile number:
`
`
`
`(v)
`
`
`
`
`
`
`
`
`
`
`
`6
`
`
`
`
`
`
`
`
`
`
`
`
`
`Case IPR2014-01259
`Patent 7,879,828
`
`
`CONCLUSION
`
`Patent Owner Wyeth LLC believes that this submission fulfills the
`
`requirements of 37 C.F.R. § 42.8(a)(2). Please contact the undersigned counsel if
`
`any additional information is required.
`
`
`
`
`
`Respectfully submitted,
`
`
`
`Dated: August 29, 2014
`
`/Stanley E. Fisher/
`Stanley E. Fisher
`Lead Attorney for Wyeth LLC
`Reg. No. 55,820
`Williams & Connolly LLP
`725 Twelfth Street, N.W.
`Washington, DC 20005
`Phone: 202-434-5289
`
`7
`
`
`
`
`
`
`
`Case IPR2014-01259
`Patent 7,879,828
`
`
`CERTIFICATE OF SERVICE
`
`The undersigned hereby certifies that the above-captioned Submission of
`
`
`
`Mandatory Notice Information Pursuant to 37 C.F.R. § 42.8(a)(2) was served on
`
`August 29, 2014, by filing this document through the Patent Review Processing
`
`System as well as delivering a copy via electronic mail upon the following
`
`attorneys of record for the Petitioner:
`
`Amir Naini
`anaini@raklaw.com
`Jay Chung
`jchung@raklaw.com
`Russ August & Kabat
`12424 Wilshire Blvd., 12th Fl.
`Los Angeles, CA 90025
`
`
`
`
`
`Respectfully submitted,
`
`/Stanley E. Fisher/
`Stanley E. Fisher
`Lead Attorney for Wyeth LLC
`Reg. No. 55,820
`Williams & Connolly LLP
`725 Twelfth Street, N.W.
`Washington, DC 20005
`Phone: 202-434-5289
`
`
`
`
`
`
`
`Dated: August 29, 2014